Cargando…

Comprehensively Exploring the Mutational Landscape and Patterns of Genomic Evolution in Hypermutated Cancers

SIMPLE SUMMARY: To identify potential genetic markers for evaluating hypermutated cancers, we investigated driver mutations, mutational signatures, tumor-associated neoantigens, and molecular cancer evolution in the genetic variants of 533 cancer patients with six different cancer types. Driver muta...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Peng-Chan, Yeh, Yu-Min, Hsu, Hui-Ping, Chan, Ren-Hao, Lin, Bo-Wen, Chen, Po-Chuan, Pan, Chien-Chang, Hsu, Keng-Fu, Hsiao, Jenn-Ren, Shan, Yan-Shen, Shen, Meng-Ru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8431047/ https://www.ncbi.nlm.nih.gov/pubmed/34503126 http://dx.doi.org/10.3390/cancers13174317

Ejemplares similares

Sequential and co-occurring DNA damage response genetic mutations impact survival in stage III colorectal cancer patients receiving adjuvant oxaliplatin-based chemotherapy
por: Lin, Peng-Chan, et al.
Publicado: (2021)

Intratumor Heterogeneity of MYO18A and FBXW7 Variants Impact the Clinical Outcome of Stage III Colorectal Cancer
por: Lin, Peng-Chan, et al.
Publicado: (2020)

The Expression Quantitative Trait Loci in Immune Response Genes Impact the Characteristics and Survival of Colorectal Cancer
por: Chan, Ren-Hao, et al.
Publicado: (2022)

MET Mutation Is a Potential Therapeutic Target for Advanced Endometrial Cancer
por: Yeh, Yu-Min, et al.
Publicado: (2021)

Adjusted CT Image-Based Radiomic Features Combined with Immune Genomic Expression Achieve Accurate Prognostic Classification and Identification of Therapeutic Targets in Stage III Colorectal Cancer
por: Huang, Yi-Ching, et al.
Publicado: (2022)

Germline susceptibility variants impact clinical outcome and therapeutic strategies for stage III colorectal cancer
por: Lin, Peng-Chan, et al.
Publicado: (2019)

Author Correction: Germline susceptibility variants impact clinical outcome and therapeutic strategies for stage III colorectal cancer
por: Lin, Peng-Chan, et al.
Publicado: (2020)

Attracting AID to targets of somatic hypermutation
por: Tanaka, Atsushi, et al.
Publicado: (2010)

Clinical Utility of a Cell-Free DNA Assay in Patients With Colorectal Cancer
por: Chan, Ren-Hao, et al.
Publicado: (2021)

Learning the heterogeneous hypermutation landscape of immunoglobulins from high-throughput repertoire data
por: Spisak, Natanael, et al.
Publicado: (2020)

Localized pmrB hypermutation drives the evolution of colistin heteroresistance
por: Kapel, Natalia, et al.
Publicado: (2022)

Treatment monitoring of colorectal cancer by integrated analysis of plasma concentration and sequencing of circulating tumor DNA
por: Yeh, Yu-Min, et al.
Publicado: (2020)

Protein evolution by hypermutation and selection in the B cell line DT40
por: Arakawa, Hiroshi, et al.
Publicado: (2008)

Selective and non‐selective bottlenecks as drivers of the evolution of hypermutable bacterial loci
por: De Ste Croix, Megan, et al.
Publicado: (2020)

Association between Altered Oncogenic Signaling Pathways and Overall Survival of Patients with Metastatic Colorectal Cancer
por: Huang, Yi-Hsuan, et al.
Publicado: (2021)

Gamma-Ray Sterilization Effects in Silica Nanoparticles/γ-APTES Nanocomposite-Based pH-Sensitive Polysilicon Wire Sensors
por: Lin, Jing-Jenn, et al.
Publicado: (2011)

Comprehensive assessment of HER2 alteration in a colorectal cancer cohort: from next-generation sequencing to clinical significance
por: Yeh, Yu-Min, et al.
Publicado: (2019)

Antibody Dynamics Simulation—A Mathematical Exploration of Clonal Deletion and Somatic Hypermutation
por: Xu, Zhaobin, et al.
Publicado: (2023)

Hypermutation of specific genomic loci of Pseudomonas putida for continuous evolution of target genes
por: Velázquez, Elena, et al.
Publicado: (2022)

Fast-forwarding evolution—Accelerated adaptation in a proofreading-deficient hypermutator herpesvirus
por: Xing, Na, et al.
Publicado: (2022)

The Promotion of V Region Hypermutation
por: Scharff, Matthew D., et al.
Publicado: (1997)

Hypermutation takes the driver’s seat
por: Schlesner, Matthias, et al.
Publicado: (2015)

Hypermutation in single-stranded DNA
por: Saini, Natalie, et al.
Publicado: (2020)

Tandem Substitutions in Somatic Hypermutation
por: Sepúlveda-Yáñez, Julieta H., et al.
Publicado: (2022)

Rare cases of medulloblastoma with hypermutation
por: Bagchi, Aditi, et al.
Publicado: (2021)

The association of cellulitis incidence and meteorological factors in Taiwan
por: Hsu, Ren-Jun, et al.
Publicado: (2019)

How to improve the problem of hotel manpower shortage in the COVID-19 epidemic environment? Exploring the effectiveness of the hotel practice training system
por: Xue, Bing-Wang, et al.
Publicado: (2022)

Directed Evolution of an Angiopoietin-2 Ligand Trap by Somatic Hypermutation and Cell Surface Display
por: Brindle, Nicholas P. J., et al.
Publicado: (2013)

The Value of Artificial Intelligence-Assisted Imaging in Identifying Diagnostic Markers of Sarcopenia in Patients with Cancer
por: Huang, Ying-Tzu, et al.
Publicado: (2022)

Hypermutation and microsatellite instability in gastrointestinal cancers
por: Yuza, Kizuki, et al.
Publicado: (2017)

Mechanisms and therapeutic implications of hypermutation in gliomas
por: Touat, Mehdi, et al.
Publicado: (2020)

Hypermutated phenotype in gliosarcoma of the spinal cord
por: Hong, Christopher S., et al.
Publicado: (2021)

Genetic and chemotherapeutic influences on germline hypermutation
por: Kaplanis, Joanna, et al.
Publicado: (2022)

AID function in somatic hypermutation and class switch recombination: AID function in somatic hypermutation and class switch recombination
por: Yu, Kefei
Publicado: (2022)

Cutting-Edge AI Technologies Meet Precision Medicine to Improve Cancer Care
por: Lin, Peng-Chan, et al.
Publicado: (2022)

Potential of Plasmon-Activated Water as a Comprehensive Active Green Energy Resource
por: Chen, Hsiao-Chien, et al.
Publicado: (2019)

Comprehensive Genomic Profiling of 282 Pediatric Low‐ and High‐Grade Gliomas Reveals Genomic Drivers, Tumor Mutational Burden, and Hypermutation Signatures
por: Johnson, Adrienne, et al.
Publicado: (2017)

Altered Gut Microbiota and Its Metabolites in Hypertension of Developmental Origins: Exploring Differences between Fructose and Antibiotics Exposure
por: Hsu, Chien-Ning, et al.
Publicado: (2021)

A Simplified Diagnostic Classification Scheme of Chemotherapy-Induced Peripheral Neuropathy
por: Huang, Han-Wei, et al.
Publicado: (2020)

Identifying protein–protein interactions in somatic hypermutation
por: Goodman, Myron F., et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_m864h46gccor2lnde6bqqa09k5